When loaded with TMZ and interleukin-15 (IL-15), cRGD-modified NKCNPs promoted dendritic cell maturation and NK cell activation, leading to significant tumor reduction and extended survival in glioma models [91]. The gene discussed is IL15; the disease is neoplasm.